We’re in New York for the @HCWCO 28th Annual Global Investment Conference and the @MorganStanley Global Healthcare Conference. We’re looking forward to discussing progress and upcoming milestones as we work toward a better treatment option for people living with #hyperinsulinism.

What a week at the European Society for Paediatric Endocrinology (ESPE) Annual Meeting! We're walking away with valuable connections and fresh insights into the latest in endocrinology research, and we're excited to bring these learnings back to our work in #hyperinsulinism.

We’ll be meeting with investors this week at the Cantor Fitzgerald Global Healthcare Conference, sharing updates on our work to advance hyperinsulinism care. Watch our fireside chat today at 3:20 pm ET here: bit.ly/4A7IX4w #Hyperinsulinism #Rezolute

Thank you to @congenitalhi for an unforgettable weekend at the Congenital Hyperinsulinism Family Conference in Marseille, France. We feel fortunate to have the opportunity to hear directly from families living with #congenitalhyperinsulinism and to connect with leading experts.

We're excited to share the latest episode of RARECast, featuring an in-depth conversation with Julie Raskin, CEO of @congenitalhi. Tune in to hear how we can better serve the #CongenitalHI community: bit.ly/4zR58M0 #RareDisease #PatientAdvocacy #Hyperinsulinism

Next week, @congenitalhi will welcome families, clinicians, researchers, advocates, and partners to Marseille, France for a 3-day Congenital Hyperinsulinism Family Conference. Rezolute is honored to support and attend this important event. Learn more: bit.ly/3SvUfyu

New JCEM article: compassionate use outcomes of investigational drug ersodetug in EAP. bit.ly/4coSGZO *𝘌𝘳𝘴𝘰𝘥𝘦𝘵𝘶𝘨 𝘪𝘴 𝘢𝘯 𝘪𝘯𝘷𝘦𝘴𝘵𝘪𝘨𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘥𝘳𝘶𝘨 & 𝘩𝘢𝘴 𝘯𝘰𝘵 𝘣𝘦𝘦𝘯 𝘢𝘱𝘱𝘳𝘰𝘷𝘦𝘥 𝘣𝘺 𝘍𝘋𝘈 𝘰𝘳 𝘢𝘯𝘺 𝘩𝘦𝘢𝘭𝘵𝘩 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘵𝘺

We're headed to the Midwest Endocrinology Society Annual Meeting to connect with leaders across the #endocrinology community. We're looking forward to discussions about advancing #hyperinsulinism care and raising awareness of this #raredisease. Details: bit.ly/45u0tSf

#CongenitalHI is a life-threatening #raredisease most commonly diagnosed in the first year of life. Today's treatment options often have suboptimal efficacy, are poorly tolerated, and have serious safety concerns. We're working to change that. Learn more: bit.ly/4fUkXsi

The Cook Children's Hyperinsulinism Center in Fort Worth, Texas, is committed to helping children living with #hyperinsulinism through multidisciplinary treatment and research, earning recognition as a @congenitalhi Center of Excellence. Learn more: bit.ly/4i0bmmb

Recently, we attended the Texas Endocrinology Association’s 2026 Annual Meeting in Dallas. We were grateful to connect with healthcare professionals to discuss opportunities to increase awareness of rare endocrine diseases. Learn more: bit.ly/4wbVrEX #TumorHI

BTIG is kicking off their virtual #Biotechnology Conference tomorrow. We’re looking forward to connecting with the investment community and discussing our two late-stage #hyperinsulinism programs. #congenitalHI #tumorHI #Rezolute

We’re thankful for specialists who bring expertise and compassionate care to the HI community. Today, we’re spotlighting the Congenital Hyperinsulinism Center at CHOP, recognized by @congenitalhi as a Hyperinsulinism Center of Excellence. Learn more: bit.ly/4fsf9pC

In July, we recognize #SarcomaAwarenessMonth 💛 This time is dedicated to raising awareness, advancing education, and amplifying the voices of patients and caregivers impacted by these rare and complex tumors, including the subset of patients whose care is complicated by NICTH.

News alert: @GoHealio highlights our recent #ENDO2026 presentation on outcomes in congenital hyperinsulinism, including the frequency of neurological and pancreatic complications in patients. Check out the full article: bit.ly/3T9sdIX #RareDisease #CongenitalHI

When a disease is rare, every experience can help us learn.💙 @congenitalhi's HI Global Registry (HIGR) brings together experiences of patients and families impacted by #congenitalHI to help fill important knowledge gaps and advance research. Learn more: bit.ly/3T5zDNl

Living with a chronic disease means navigating daily challenges that often go unseen. On #ChronicDiseaseDay, we honor the resilience and strength of the millions of people affected by rare diseases like congenital and tumor #hyperinsulinism. Learn more: bit.ly/4ygHtDO

Families navigating congenital #hyperinsulinism are managing a complex, life-threatening condition with limited effective options. We believe they deserve innovative treatments and better care. That's what drives us every day. Learn more: bit.ly/4aEdjAm

We recognize #NationalCancerSurvivorMonth alongside the @AACR and the #neuroendocrine tumor (NET) community. We honor the courage of survivors and are reminded of the power of support, hope, and inspiration through every survivorship journey. Learn more: bit.ly/4amjBof

We’re proud to spotlight two educational resources designed to help patients, caregivers, and healthcare professionals better understand and navigate the tumor #hyperinsulinism journey. Learn more about: Insulinoma: bit.ly/4uI0gVM NICTH: bit.ly/4oxAO3X